Compare RNA & ALSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNA | ALSN |
|---|---|---|
| Founded | 2012 | 1915 |
| Country | United States | United States |
| Employees | N/A | 4000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 227.6M | 9.9B |
| IPO Year | 2025 | 2011 |
| Metric | RNA | ALSN |
|---|---|---|
| Price | $14.31 | $125.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 8 |
| Target Price | $69.26 | ★ $115.38 |
| AVG Volume (30 Days) | 381.1K | ★ 609.2K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.84% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.33 |
| Revenue | N/A | ★ $3,010,000,000.00 |
| Revenue This Year | $88.12 | $83.29 |
| Revenue Next Year | $18.11 | $11.91 |
| P/E Ratio | ★ N/A | $17.52 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.95 | $76.01 |
| 52 Week High | $73.06 | $130.83 |
| Indicator | RNA | ALSN |
|---|---|---|
| Relative Strength Index (RSI) | 26.62 | 60.95 |
| Support Level | $13.06 | $110.01 |
| Resistance Level | $72.75 | $128.85 |
| Average True Range (ATR) | 0.56 | 3.27 |
| MACD | 1.73 | 1.17 |
| Stochastic Oscillator | 91.22 | 73.42 |
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.